Evaluation of serum β-human chorionic gonadotropin and progesterone monitoring in medicinal conservative treatment for ectopic pregnancy

REN Chun-hua,任春花,赵爱民
DOI: https://doi.org/10.3969/j.issn.1674-8115.2009.04.022
2009-01-01
Abstract:Objective: To investigate the value of serum β-human chorionic gonadotropin (β-HCG) and progesterone monitoring in medicinal conservative treatment for ectopic pregnancy. Methods: Sixty patients with ectopic pregnancy treated with methotrexate were divideded into group A (n = 39, β-HCG < 2000 mIU/mL and progesterone < 10 ng/mL) and group B (n = 21, β-HCG ≥ 2000 mIU/mL and progesterone ≥ 10 ng/mL) according to the levels of serum β-HCG and progesterone before treatment. Serum β-HCG and progesterone were successively mornitored before and after treatment. The time of serum β-HCG and progesterone declining to normal levels was recorded, and the amplitude of decrease of serum β-HCG and progesterone 4 d after treatment was compared between the patients with successful treatment and those without. Results: The serum β-HCG and progesterone levels before treatment were (1206 ± 608) mIU/mL and (5.92 ± 2.22) ng/mL, respectively in group A, and those were (3231 ± 698) mIU/mL and (11.48 ± 1.07) ng/mL, respectively in group B. The curative rates were 79.48% and 38.09%, respectively in group A and group B. There were significant differences in curative rate and β-HCG and progesterone levels between these two groups (P < 0.01). Progesterone level decreased more significantly in the patients with successful treatment than in those without in these two groups 4 d after treatment (P < 0.05), while there was no significant difference in serum β-HCG level between them (P > 0.05). The time of serum progesterone level declining to normal level was significantly shorter than that of β-HCG in both group A and group B (P < 0.01). Conclusion: During the medicinal conservative treatment for ectopic pregnancy, the amplitude of decrease of serum progesterone is larger and the time of serum progesterone level declining to normal one is shorter than those of β-HCG. Therefore, serum progesterone monitoring is better than β-HCG monitoring.
What problem does this paper attempt to address?